https://www.triomedicines.com/netazepide-further-studies 2019-08-15T08:33:14+00:00 monthly 0.8 https://www.triomedicines.com/netazepide-background 2019-09-23T14:16:12+00:00 monthly 0.8 https://www.triomedicines.com/netazepide-a-gastrincholecystokinin-2-receptor-antagonist-can-eradicate-gastric-neuroendocrine-tumours-in-patients-with-autoimmune-chronic-atrophic-gastritis 2019-03-26T12:52:14+00:00 monthly 0.8 https://www.triomedicines.com/1282-2 2019-03-26T12:55:35+00:00 monthly 0.8 https://www.triomedicines.com/the-gastrin-receptor-antagonist-netazepide-yf476-in-patients-with-type-1-gastric-enterochromaffin-like-cell-neuroendocrine-tumours-review-of-long-term-treatment 2019-03-26T13:06:25+00:00 monthly 0.8 https://www.triomedicines.com/potential-clinical-indications-for-a-cck2-receptor-antagonist 2019-03-26T13:07:10+00:00 monthly 0.8 https://www.triomedicines.com/gastrin-stimulates-a-cholecystokinin-2-receptor-expressing-cardia-progenitor-cell-and-promotes-progression-of-barretts-like-esophagus 2019-03-26T13:08:07+00:00 monthly 0.8 https://www.triomedicines.com/skeletal-effects-of-a-gastrin-receptor-antagonist-in-hkatpase-beta-subunit-ko-mice 2019-03-26T13:14:34+00:00 monthly 0.8 https://www.triomedicines.com/gastrin-induced-mir-222-promotes-gastric-tumor-development-by-suppressing-p27kip1 2019-03-26T13:15:19+00:00 monthly 0.8 https://www.triomedicines.com/gastric-neuroendocrine-tumors-prevalence-in-europe-usa-and-japan-and-rationale-for-treatment-with-a-gastrincck2-receptor-antagonist 2019-03-26T13:16:38+00:00 monthly 0.8 https://www.triomedicines.com/effect-of-netazepide-a-gastrincck2-receptor-antagonist-on-gastric-acid-secretion-and-rabeprazole-induced-hypergastrinaemia-in-healthy-subjects 2019-03-26T13:17:41+00:00 monthly 0.8 https://www.triomedicines.com/single-oral-doses-of-netazepide-yf476-a-gastrin-receptor-antagonist-cause-dose-dependent-sustained-increases-in-gastric-ph-compared-with-placebo-and-ranitidine-in-healthy-subjects 2019-03-26T13:18:13+00:00 monthly 0.8 https://www.triomedicines.com/the-gastrin-receptor-antagonist-netazepide-yf476-prevents-oxyntic-mucosal-inflammation-induced-by-helicobacter-pylori-infection-in-mongolian-gerbils 2019-03-26T13:18:41+00:00 monthly 0.8 https://www.triomedicines.com/netazepide-a-gastrincck2-receptor-antagonist-causes-dose-dependent-persistent-inhibition-of-the-responses-to-pentagastrin-in-healthy-subjects 2019-03-26T13:19:12+00:00 monthly 0.8 https://www.triomedicines.com/effect-of-repeated-doses-of-netazepide-a-gastrin-receptor-antagonist-omeprazole-and-placebo-on-24%e2%80%89h-gastric-acidity-and-gastrin-in-healthy-subjects 2019-03-26T13:19:44+00:00 monthly 0.8 https://www.triomedicines.com/the-type-2-cckgastrin-receptor-antagonist-yf476-acutely-prevents-nsaid-induced-gastric-ulceration-while-increasing-inos-expression 2019-03-26T13:20:31+00:00 monthly 0.8 https://www.triomedicines.com/ceclazepide 2019-08-15T08:35:53+00:00 monthly 0.8 https://www.triomedicines.com/tr8 2019-08-15T08:46:42+00:00 monthly 0.8 https://www.triomedicines.com/netazepide-studies 2019-09-24T15:12:23+00:00 monthly 0.8 https://www.triomedicines.com/publications 2019-06-26T10:22:23+00:00 monthly 0.8 https://www.triomedicines.com/publications22607579 2019-03-26T13:20:58+00:00 monthly 0.8 https://www.triomedicines.com/our-founders 2019-09-10T11:48:51+00:00 monthly 0.8 https://www.triomedicines.com/pipeline 2019-09-25T12:24:00+00:00 monthly 0.8 https://www.triomedicines.com/therapeutic-focus 2019-03-26T12:48:55+00:00 monthly 0.8 https://www.triomedicines.com/tr4 2019-08-14T18:38:33+00:00 monthly 0.8 https://www.triomedicines.com/about-us 2019-08-14T18:00:55+00:00 monthly 0.8 https://www.triomedicines.com/publications20144901 2019-03-26T13:22:08+00:00 monthly 0.8 https://www.triomedicines.com/training 2019-02-06T12:08:28+00:00 monthly 0.8 https://www.triomedicines.com/careers 2019-07-12T12:24:28+00:00 monthly 0.8 https://www.triomedicines.com/contact-us 2019-07-16T09:03:32+00:00 monthly 0.8 https://www.triomedicines.com/projects 2017-10-26T09:24:03+00:00 monthly 0.8 https://www.triomedicines.com/generic-text 2019-02-06T11:30:05+00:00 monthly 0.8 https://www.triomedicines.com/ 2019-09-10T11:47:34+00:00 monthly 1